Skip to main content
PMC home page
Springer logoLink to Springer
. 2021 Jul 3;60(12):1635. doi: 10.1007/s40262-021-01055-5

Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Ken Ogasawara 1,✉, Michael Dodds 2, Timothy Mack 1, James Lymp 3, Justine Dell’Aringa 3, Jeff Smith 3
PMCID: PMC8613098  PMID: 34216384

Correction to: Clinical Pharmacokinetics 10.1007/s40262-021-01039-5

In this article, the affiliation details of Corresponding Author ‘Ken Ogasawara’ was incorrectly given as

Cellular Therapy & Hematology, Clinical Pharmacology & Pharmacometrics, Bristol Myers Squibb, Princeton, NJ, USA

It should have been

Bristol Myers Squibb, Princeton, NJ, USA

The original article has been corrected

Articles from Clinical Pharmacokinetics are provided here courtesy of Springer

RESOURCES